Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape

Ghose, Aruni; Lapitan, Patricia; Apte, Vedika; Ghosh, Adheesh; Kandala, Abhinav; Basu, Sreejana; Parkes, Jo; Shinde, Sayali D.; Boussios, Stergios; Sharma, Anand; Das, Prantik; Vasdev, Nikhil; Rebuzzi, Sara E.; Ürün, Yüksel; Kanesvaran, Ravindran; Maniam, Akash; Banna, Giuseppe L.

doi:10.1007/s11912-024-01524-7

Curr Oncol Rep

2024

DOI: 10.1007/s11912-024-01524-7

|View full text |Cite

Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape

Aruni Ghose,

Patricia Lapitan,

Vedika Apte

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 61 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Antikörper-Wirkstoff-Konjugate in der Uroonkologie

Darr,

Hilser,

Yesilyurt

et al. 2024

Uro-News

View full text Add to dashboard Cite

Antikörper-Wirkstoff-Konjugate in der Uroonkologie

Darr,

Hilser,

Yesilyurt

et al. 2024

Uro-News

View full text Add to dashboard Cite

The Application of Prostate Specific Membrane Antigen in the Diagnosis and Treatment of Prostate Cancer: Status and Challenge

Zeng,

Xie,

Chai

et al. 2024

OTT

View full text Add to dashboard Cite

In recent years, the incidence of prostate cancer has been increasing globally. Early stage of the disease can obtain a better clinical prognosis from surgery and endocrine therapy. The progression of advanced stage varies significantly between individuals, with some patients developing metastatic castration-resistant prostate cancer after standardized treatment. Therefore, staging of prostate cancer by accurate imaging is particularly important for the clinical management of patients. Simultaneously, the development of targeted therapy is also urgent for the treatment of advanced prostate cancer. Prostate specific membrane antigen as a prostate specific target has been widely used in the diagnosis and treatment of prostate cancer. This review summarizes the latest research progress of targeted prostate specific membrane antigen in the diagnosis and treatment of prostate cancer in detail, analyzes their value and challenges.

show abstract

Antibody‑drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (Review)

Yang,

Wang,

Gong

et al. 2024

Oncol Rep

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape

Cited by 3 publications

References 61 publications

Antikörper-Wirkstoff-Konjugate in der Uroonkologie

Antikörper-Wirkstoff-Konjugate in der Uroonkologie

The Application of Prostate Specific Membrane Antigen in the Diagnosis and Treatment of Prostate Cancer: Status and Challenge

Antibody‑drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (Review)

Contact Info

Product

Resources

About